RAFA LABORATORIES LTD: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: CKDNTKNDPMJ6
3contracts won
$54,761,844total obligated
$11,997,762median contract
Sep 30, 2025most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 3 | $54,761,844 |
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
75A50325C00020 · NAICS 325412 Pharmaceutical Preparation Manufacturing |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$33,392,937 Potential value: $46,212,577 |
Sep 30, 2025 Ends: Sep 29, 2027 |
| THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVIC…
75A50125C00018 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$11,997,762 Potential value: $147,733,954 |
Sep 29, 2025 Ends: Dec 31, 2028 |
| THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT, INCLUDING U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL, OF ATROPIN…
75A50123C00055 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$9,371,145 Potential value: $14,715,580 |
Sep 19, 2023 Ends: Aug 04, 2028 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.